BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29361822)

  • 1. Ligand-Independent Epidermal Growth Factor Receptor Overexpression Correlates with Poor Prognosis in Colorectal Cancer.
    Yun S; Kwak Y; Nam SK; Seo AN; Oh HK; Kim DW; Kang SB; Lee HS
    Cancer Res Treat; 2018 Oct; 50(4):1351-1361. PubMed ID: 29361822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
    Koutras A; Kalogeras KT; Wirtz RM; Alexopoulou Z; Bobos M; Zagouri F; Veltrup E; Timotheadou E; Gogas H; Pentheroudakis G; Pisanidis N; Magkou C; Christodoulou C; Bafaloukos D; Papakostas P; Aravantinos G; Pectasides D; Kalofonos HP; Fountzilas G
    J Transl Med; 2015 May; 13():171. PubMed ID: 26021752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis.
    Révillion F; Lhotellier V; Hornez L; Bonneterre J; Peyrat JP
    Ann Oncol; 2008 Jan; 19(1):73-80. PubMed ID: 17962208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the ERBB Family of Ligands and Receptors in Gastric Cancer.
    Byeon SJ; Lee HS; Kim MA; Lee BL; Kim WH
    Pathobiology; 2017; 84(4):210-217. PubMed ID: 28399526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of epidermal growth factor receptor 4 in oral leukoplakia.
    Kobayashi H; Kumagai K; Gotoh A; Eguchi T; Yamada H; Hamada Y; Suzuki S; Suzuki R
    Int J Oral Sci; 2013 Mar; 5(1):14-20. PubMed ID: 23492901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the EGF family in gastric cancer: downregulation of HER4 and its activating ligand NRG4.
    Nielsen TO; Friis-Hansen L; Poulsen SS; Federspiel B; Sorensen BS
    PLoS One; 2014; 9(4):e94606. PubMed ID: 24728052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of epidermal growth factor receptor family receptors and ligands in a mutant K-ras group of patients with colorectal cancer.
    Nagaoka T; Kitaura K; Miyata Y; Kumagai K; Kaneda G; Kanazawa H; Suzuki S; Hamada Y; Suzuki R
    Mol Med Rep; 2016 Apr; 13(4):3514-20. PubMed ID: 26935861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forkhead Box q1 promotes invasion and metastasis in colorectal cancer by activating the epidermal growth factor receptor pathway.
    Zhang JJ; Cao CX; Wan LL; Zhang W; Liu ZJ; Wang JL; Guo Q; Tang H
    World J Gastroenterol; 2022 May; 28(17):1781-1797. PubMed ID: 35633908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR and EGFR ligands in serum in healthy women; reference intervals and age dependency.
    Kjær IM; Olsen DA; Alnor A; Brandslund I; Bechmann T; Madsen JS
    Clin Chem Lab Med; 2019 Nov; 57(12):1948-1955. PubMed ID: 31323001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4.
    Riese DJ; Kim ED; Elenius K; Buckley S; Klagsbrun M; Plowman GD; Stern DF
    J Biol Chem; 1996 Aug; 271(33):20047-52. PubMed ID: 8702723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor mediates stress-induced expression of its ligands in rat gastric epithelial cells.
    Miyazaki Y; Hiraoka S; Tsutsui S; Kitamura S; Shinomura Y; Matsuzawa Y
    Gastroenterology; 2001 Jan; 120(1):108-16. PubMed ID: 11208719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.
    Tanaka Y; Miyamoto S; Suzuki SO; Oki E; Yagi H; Sonoda K; Yamazaki A; Mizushima H; Maehara Y; Mekada E; Nakano H
    Clin Cancer Res; 2005 Jul; 11(13):4783-92. PubMed ID: 16000575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine expression of the epidermal growth factor receptor ligand heparin-binding EGF-like growth factor in cervical cancer.
    Schrevel M; Osse EM; Prins FA; Trimbos JBMZ; Fleuren GJ; Gorter A; Jordanova ES
    Int J Oncol; 2017 Jun; 50(6):1947-1954. PubMed ID: 28498437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the epidermal growth factor system in human middle ear cholesteatoma.
    Thorup MB; Munk M; Poulsen SS; Gaihede M; Nexo E; Sorensen BS; Ovesen T
    Acta Otolaryngol; 2014 Feb; 134(2):124-34. PubMed ID: 24256036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of EGFR ligands on endocytic sorting of the receptor.
    Roepstorff K; Grandal MV; Henriksen L; Knudsen SL; Lerdrup M; Grøvdal L; Willumsen BM; van Deurs B
    Traffic; 2009 Aug; 10(8):1115-27. PubMed ID: 19531065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internalization mechanisms of the epidermal growth factor receptor after activation with different ligands.
    Henriksen L; Grandal MV; Knudsen SL; van Deurs B; Grøvdal LM
    PLoS One; 2013; 8(3):e58148. PubMed ID: 23472148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression.
    el-Marjou A; Delouvée A; Thiery JP; Radvanyi F
    Carcinogenesis; 2000 Dec; 21(12):2211-8. PubMed ID: 11133810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.
    Pentheroudakis G; Kotoula V; De Roock W; Kouvatseas G; Papakostas P; Makatsoris T; Papamichael D; Xanthakis I; Sgouros J; Televantou D; Kafiri G; Tsamandas AC; Razis E; Galani E; Bafaloukos D; Efstratiou I; Bompolaki I; Pectasides D; Pavlidis N; Tejpar S; Fountzilas G
    BMC Cancer; 2013 Feb; 13():49. PubMed ID: 23374602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and regulation of c-ERBB ligands in human head and neck squamous carcinoma cells.
    O-Charoenrat P; Rhys-Evans P; Eccles S
    Int J Cancer; 2000 Dec; 88(5):759-65. PubMed ID: 11072245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER family receptor and ligand status in thymic carcinoma.
    Weissferdt A; Lin H; Woods D; Tang X; Fujimoto J; Wistuba II; Moran CA
    Lung Cancer; 2012 Sep; 77(3):515-21. PubMed ID: 22726920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.